Aim: To screen the antibodies against transferrin receptor(TfR) from a full humanized phage antibody library.

Methods: Total RNA was extracted from HeLa cells and then the extracellular domain of TfR gene was amplified by RT-PCR in two parts. A full-length gene of extracellular domain was obtained by two rounds of PCR. The gene was inserted into the plasmid pPROEX(TM) HTa and transformed into E.coli BL21(DE3). Transformant was expressed under 1 mmol/L IPTG induction. The target protein was purified and refolded by one-step affinity chromatography with Ni(+)-NTA agarose. The antibodies against TfR were screened by proteins coupled to immunotubes from a whole-hog humanized phage single chain antibody library with sink size of 10(13) cfu/L.

Results: The extracellular domain of TfR gene with about 1.9 kb was obtained. DNA sequencing of TfR gene proved to be identical to the published sequence. Eight single chain antibodies specifically binding to human TfR have been screened.

Conclusion: Antibodies specifically binding to natural TfR can be obtained by screening the library with refolded protein, which lays the foundation for treatment of tumor and central nervous system diseases.

Download full-text PDF

Source

Publication Analysis

Top Keywords

extracellular domain
12
tfr gene
12
antibodies transferrin
8
humanized phage
8
domain tfr
8
single chain
8
antibodies binding
8
tfr
6
antibodies
5
gene
5

Similar Publications

Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody-drug conjugates.

Proc Natl Acad Sci U S A

January 2025

Laboratory of Precision Medicine and Biopharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

Recurrent missense mutations in the human epidermal growth factor receptor 2 (HER2) have been identified across various human cancers. Among these mutations, the active S310F mutation in the HER2 extracellular domain stands out as not only oncogenic but also confers resistance to pertuzumab, an antibody drug widely used in clinical cancer therapy, by impeding its binding. In this study, we have successfully employed computational-aided rational design to undertake directed evolution of pertuzumab, resulting in the creation of an evolved pertuzumab variant named Ptz-SA.

View Article and Find Full Text PDF

The blood-brain barrier (BBB) maintains brain homeostasis but also prevents most drugs from entering the brain. No paracellular diffusion of solutes is allowed because of tight junctions that are made impermeable by the expression of claudin5 (CLDN5) by brain endothelial cells. The possibility of regulating the BBB permeability in a transient and reversible fashion is in strong demand for the pharmacological treatment of brain diseases.

View Article and Find Full Text PDF

The tightly-regulated spatial and temporal distribution of zinc ion concentrations within cellular compartments is controlled by two groups of Zn transporters: the 14-member ZIP/SLC39 family, facilitating Zn influx into the cytoplasm from the extracellular space or intracellular organelles; and the 10-member ZnT/SLC30 family, mobilizing Zn in the opposite direction. Genetic aberrations in most zinc transporters cause human syndromes. Notably, previous studies demonstrated osteopenia and male-specific cardiac death in mice lacking the ZnT5/ zinc transporter, and suggested association of two homozygous frameshift variants with perinatal mortality in humans, due to hydrops fetalis and hypertrophic cardiomyopathy.

View Article and Find Full Text PDF

Proper adhesion of cells to their environment is essential for the normal functioning of single cells and multicellular organisms. To attach to the extracellular matrix (ECM), mammalian cells form integrin adhesion complexes consisting of many proteins that together link the ECM and the actin cytoskeleton. Similar to mammalian cells, the amoeboid cells of the protist Dictyostelium discoideum also use multiprotein adhesion complexes to control their attachment to the underlying surface.

View Article and Find Full Text PDF

High molecular weight hyaluronan (HMWH) inhibits hyperalgesia induced by diverse pronociceptive inflammatory mediators and their second messengers, in rats of both sexes. However, the hyperalgesia induced by ligands at 3 pattern recognition receptors, lipopolysaccharide (a toll-like receptor 4 agonist), lipoteichoic acid (a toll-like receptor 2/6 agonist), and nigericin (a NOD-like receptor family, pyrin domain containing 3 activator), and oxaliplatin and paclitaxel chemotherapy-induced peripheral neuropathy are only attenuated in males. After gonadectomy or intrathecal administration of an antisense to G-protein-coupled estrogen receptor 30 (GPER) mRNA, HMWH produces antihyperalgesia in females.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!